Approximately 50% of these high-risk patients with acalculus cholecystitis will develop [...] during their hospitalization. Supportive treatment with intravenous antibiotic coverage of anaerobic and gram-negative bacteria is required. Definitive therapy with cholecystectomy is preferred but may be contraindicated in severely ill patients
Answer
cholangitis, empyema, gangrene, or gallbladder perforation
Question
Approximately 50% of these high-risk patients with acalculus cholecystitis will develop [...] during their hospitalization. Supportive treatment with intravenous antibiotic coverage of anaerobic and gram-negative bacteria is required. Definitive therapy with cholecystectomy is preferred but may be contraindicated in severely ill patients
Answer
?
Question
Approximately 50% of these high-risk patients with acalculus cholecystitis will develop [...] during their hospitalization. Supportive treatment with intravenous antibiotic coverage of anaerobic and gram-negative bacteria is required. Definitive therapy with cholecystectomy is preferred but may be contraindicated in severely ill patients
Answer
cholangitis, empyema, gangrene, or gallbladder perforation
If you want to change selection, open original toplevel document below and click on "Move attachment"
Parent (intermediate) annotation
Open it Approximately 50% of these high-risk patients with acalculus cholecystitis will develop cholangitis, empyema, gangrene, or gallbladder perforation during their hospitalization. Supportive treatment with intravenous antibiotic coverage of anaerobic and gram-negative bacteria is required. Definitive therapy with cholecystectomy is p
Original toplevel document (pdf)
owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p2707
Summary
status
not learned
measured difficulty
37% [default]
last interval [days]
repetition number in this series
0
memorised on
scheduled repetition
scheduled repetition interval
last repetition or drill
Details
No repetitions
Discussion
Do you want to join discussion? Click here to log in or create user.